Search


 
Results 1 - 3 of about 3 for "FDA update".

IBS-D drug should not be prescribed to patients without ...

The FDA suggests that clinicians should consider alternatives to eluxadoline in this population.

New drug approved for carcinoid syndrome diarrhea | ACP ...

The drug reduces the frequency of diarrhea by inhibiting the production of serotonin by carcinoid tumors.

Drug for chronic idiopathic constipation approved | ACP ...

The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.